Scottish newspaper The Glasgow Herald listed its top ten new Scottish businesses - young companies that are all operating successfully, and sitting at No 6 was Aberdeen-based biotech company Haptogen
"The UK is leading the way in Europe in knowledge based and high-tech businesses.
"Increasing the amount of knowledge transfer from our science and engineering base has been a major objective of the government.
"Programmes have been very successful in stimulating more knowledge transfer from universities in terms of licensing, patents, spin-off companies and contract work for industry," said David Sainsbury, UK science minister.
"The market value of university spin-outs floated on the stock market in 2004 was £604 million".
Haptogen is an example of this success and this new accolade comes hot on the heels of Haptogen directors, Jim Reid, chief executive officer, and Andy Porter, chief scientific officer, being honoured with the title 2005 Ernst and Young UK Entrepreneur of the Year in the science and technology category.
Jim Reid commented: "I believe it's a very exciting time for Scottish business - and for Haptogen.
"We continue to expand our research and commercial teams - and our major collaborative research agreements, such as that with a leading Korean pharmaceutical company for the development of novel antibiotics, are progressing well".
Haptogen spun-out from the University of Aberdeen, one of the world's leading centres in antibody engineering.
The company was formed in 2002, a time when the challenges of establishing a drug development company were significant.
The entrepreneurial spirit of the founders ensured that the company quickly generated revenue without needing to rely on external funding to grow the business.
